BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 12085361)

  • 1. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
    Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
    Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.
    Fattinger K; Cattori V; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2000 Jul; 32(1):82-6. PubMed ID: 10869292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation.
    Tirona RG; Leake BF; Wolkoff AW; Kim RB
    J Pharmacol Exp Ther; 2003 Jan; 304(1):223-8. PubMed ID: 12490595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1.
    van Montfoort JE; Stieger B; Meijer DK; Weinmann HJ; Meier PJ; Fattinger KE
    J Pharmacol Exp Ther; 1999 Jul; 290(1):153-7. PubMed ID: 10381771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of albumin binding on the substrate transport mediated by human hepatocyte transporters OATP2 and OATP8.
    Cui Y; Walter B
    J Gastroenterol; 2003; 38(1):60-8. PubMed ID: 12560923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver.
    Kullak-Ublick GA; Ismair MG; Stieger B; Landmann L; Huber R; Pizzagalli F; Fattinger K; Meier PJ; Hagenbuch B
    Gastroenterology; 2001 Feb; 120(2):525-33. PubMed ID: 11159893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
    Bachmakov I; Glaeser H; Fromm MF; König J
    Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver.
    Ismair MG; Stieger B; Cattori V; Hagenbuch B; Fried M; Meier PJ; Kullak-Ublick GA
    Gastroenterology; 2001 Nov; 121(5):1185-90. PubMed ID: 11677211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J; Müller F; Mieth M; Fromm MF; König J
    Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
    Treiber A; Schneiter R; Häusler S; Stieger B
    Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.
    Pizzagalli F; Hagenbuch B; Stieger B; Klenk U; Folkers G; Meier PJ
    Mol Endocrinol; 2002 Oct; 16(10):2283-96. PubMed ID: 12351693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OATP8/1B3-mediated cotransport of bile acids and glutathione: an export pathway for organic anions from hepatocytes?
    Briz O; Romero MR; Martinez-Becerra P; Macias RI; Perez MJ; Jimenez F; San Martin FG; Marin JJ
    J Biol Chem; 2006 Oct; 281(41):30326-35. PubMed ID: 16877380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
    Hirano M; Maeda K; Shitara Y; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine.
    Chen C; Wu ZT; Ma LL; Ni X; Lin YF; Wang L; Chen KP; Huang CG; Pan G
    Xenobiotica; 2015; 45(12):1138-46. PubMed ID: 26068524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.
    Mahagita C; Grassl SM; Piyachaturawat P; Ballatori N
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G271-8. PubMed ID: 17412826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin.
    Briz O; Serrano MA; MacIas RI; Gonzalez-Gallego J; Marin JJ
    Biochem J; 2003 May; 371(Pt 3):897-905. PubMed ID: 12568656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia.
    Campbell SD; de Morais SM; Xu JJ
    Chem Biol Interact; 2004 Nov; 150(2):179-87. PubMed ID: 15535988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.
    Shimizu M; Fuse K; Okudaira K; Nishigaki R; Maeda K; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2005 Oct; 33(10):1477-81. PubMed ID: 16014768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
    Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
    Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.